Penumbra, Inc. (the “Company”) ( NYSE: PEN ), a global healthcare company focused on innovative therapies, today announced certain unaudited preliminary revenue results for the fourth quarter and full year 2020 ahead of its participation at the 39 th Annual J.P. Morgan Healthcare Conference on January 11-14, 2021 .
January 11, 2021
· 9 min read